ERGASHEVA GULSHAN TOKHIROVNA. BREAKTHROUGH THERAPIES IN TYPE 2 DIABETES: ADVANCED ROLE OF GLP-1 RECEPTOR AGONISTS AND SGLT2 INHIBITORS. International Multidisciplinary Journal for Research & Development, [S. l.], v. 13, n. 4, p. 882–885, 2026. Disponível em: https://www.ijmrd.in/index.php/imjrd/article/view/5715. Acesso em: 28 apr. 2026.